347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival
The Readout Loud
Navigating AI's Role in Drug Development
This chapter explores the potential and challenges of using AI in drug development, highlighting bottlenecks in clinical trials despite initial successes. It emphasizes the need for innovative approaches and resource allocation to enhance late-stage drug efficacy and patient outcomes.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
